depletion of exosomes and circulating viruses

Aethlon Medical develops immunotherapeutic technologies to combat cancer and infectious disease. Its Aethlon Hemopurifier® is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and circulating viruses. The FDA has designated the Hemopurifier® as a Breakthrough Device for advanced or metastatic cancer unresponsive or intolerant to standard-of-care therapy and for life-threatening viruses not addressed with approved therapies. The company is conducting a safety, feasibility and dose-finding clinical trial of the Hemop

Read more

clinical trialsimmunotherapeutic technology development